Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
Message: ELISA (450 nm), flash Chemiluminescense Immunoassay (CIA)
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The following link shows our products.
http://www.genoprice.com/BioCurexBro...
SERUM ASSAYS TO DETECT RECAF™ (THE RECEPTOR FOR ALPHA-FETOPROTEIN) IN SERUM FORMATS: ELISA (450 nm), flash Chemiluminescense Immunoassay (CIA) and
125
I Radioimmunoassay (RIA).
RECAF™ is a novel biochemical marker which is
expressed in the cells of cancer patients.
PRODUCT FEATURES
Catalog Numbers: CIA-92001, RIA 92001
96 Well Microplate Format Detection System: CIA or RIA Individual Strips/Wells: Yes High Sensitivity: 80-90% High Speci!city: 95% Rapid Assay Time: 3 hours Sample Type: Serum Sample Size: 5 microliters Sample Size: < 50 microliters Applicable to Multiple Cancer Types: Ovarian, Prostate, Breast, Stomach, Pancreas, Lymphomas, Cervical, LungLung
Available for research use only/investigational use only.
Reagents available for AnalyteSpeci!c Reagent (ASR) in
the United States and Canada.
Cancer type
Sensitivity with 95%
Specificity
Sensitivity with 99%
Specificity Number
Ovarian Ca 96% 92% 162
Stomach Ca 90% 87% 31
Lung Ca 91% 87% 32
Breast Ca 93% 90% 88
Prostate Ca vs. Normal 99% 95% 20
TOTAL 94% 91% 333
Breast Benign* 0 0 22
Prostate Benign* 25% 5% 77
*At the 95% cutoff value, a small percentage of benign breast and prostate samples were positive. Increasing the cut-off value to include
99% of normal individuals reduces the percentage of false positives, at the expense of a slight decrease in sensitivity
BioCurex, Inc
215-7080 River Road
Richmond, BC V6X 1X5
Canada
Phone: (604) 207-9150
Fax: (604) 207-9165
Email:
info@biocurex.com
Website:
www.biocurex.com
Distributed By:
BioCurex, Inc
215-7080 River Road
Richmond, BC V6X 1X5
Canada
BioCurex, Inc
215-7080 River Road
Richmond, BC V6X 1X5
Canada
Phone: (604) 207-9150
Fax: (604) 207-9165
Email:
info@biocurex.com
Website:
www.biocurex.com
Distributed By:
SERUM ASSAYS TO DETECT RECAF™ (THE RECEPTOR FOR ALPHA-FETOPROTEIN) IN SERUM
In a study comparing normal patients, patients with BPH (Benign Prostate Hyperplasia) and
patients with prostate cancer:
1) RECAF™ detected early stage prostate cancer
2) RECAF™ discriminated prostate cancer from BPH substantially better than total-PSA
(tPSA) or free-PSA (fPSA)
3) RECAF™ discriminated between BPH and prostate cancer significantly better than
thethe generally accepted discrimination obtainable with tPSA or fPSA using tPSA or
Cancer Stage SENSITIVITY SPECIFICITY NUMBER OF SAMPLES
Stage I 90% 100% 42
Stage II 93% 100% 45
In a blinded study RECAF™ has been shown to detect early stage breast cancers. Data collected on
Stage I and Stage II cancers are shown below.
#Typical data obtained with a Radioimmunoassay (RIA).
Loading...
Loading...
New Message
Please
login
to post a reply